Denver Nuggets · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 15.4 | 4.7 | 3.0 | 2.3 | 10.0 | 0.0 | 0.0 | 1.0 | 0.3 | 2.0 |
| 16.7% |
| 1.3 |
| 2.3 |
| 57.1% |
| 0.0 |
| 0.0 |
| 0.0% |
| Last 5 | 5 | 10.0 | 2.8 | 2.0 | 1.6 | 6.4 | 0.2 | 0.0 | 0.6 | 0.2 | 1.2 | 16.7% | 0.8 | 1.6 | 50.0% | 0.0 | 0.0 | 0.0% |
| Last 10 | 10 | 8.6 | 2.4 | 1.3 | 1.3 | 5.0 | 0.1 | 0.0 | 0.5 | 0.3 | 0.9 | 33.3% | 0.6 | 1.5 | 40.0% | 0.0 | 0.1 | 0.0% |
| Last 20 | 20 | 11.5 | 2.8 | 1.1 | 2.1 | 6.0 | 0.2 | 0.0 | 0.6 | 0.6 | 1.2 | 48.0% | 0.5 | 1.8 | 27.8% | 0.1 | 0.1 | 33.3% |
| Season | 67 | 14.6 | 3.0 | 1.1 | 2.4 | 6.5 | 0.6 | 0.0 | 0.4 | 0.5 | 1.2 | 44.4% | 0.6 | 2.0 | 29.2% | 0.1 | 0.1 | 77.8% |
high on-ball creation, high assist rate, low contested shots per minute, low offensive rebounding
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | DEN @ SAS | W | 20.8 | 5 | 5 | 4 | 0 | 0 | 1 | 2 | 7 | 28.6% | 1 | 4 | 25.0% | 0 | 0 | 0.0% | 6.0 |
| 2026-04-10 | DEN vs. OKC | W | 23.3 | 9 | 4 | 3 | 0 | 0 | 2 | 3 | 6 | 50.0% | 3 | 3 | 100.0% | 0 | 0 | 0.0% | 7.0 |
| 2026-04-04 | DEN vs. SAS | W | 2.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 4.0 |
| 2026-03-29 | DEN vs. GSW | W | 1.9 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 2.0 |
| 2026-03-22 | DEN vs. POR | W | 1.9 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0.0 |
| 2026-03-20 | DEN vs. TOR | W | 3.4 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 1.0 |
| 2026-03-17 | DEN vs. PHI | W | 9.8 | 5 | 1 | 2 | 0 | 0 | 0 | 2 | 4 | 50.0% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 2.0 |
| 2026-03-12 | DEN @ SAS | W | 3.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -11.0 |
| 2026-03-11 | DEN vs. HOU | W | 7.5 | 2 | 0 | 2 | 0 | 0 | 0 | 1 | 2 | 50.0% | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 3.0 |
| 2026-03-06 | DEN vs. NYK | L | 12.0 | 3 | 1 | 1 | 0 | 0 | 2 | 1 | 4 | 25.0% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | -14.0 |
| 2026-03-05 | DEN vs. LAL | W | 5.7 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 2 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 4.0 |
| 2026-02-27 | DAL vs. MEM | L | 21.6 | 6 | 0 | 4 | 0 | 0 | 0 | 2 | 7 | 28.6% | 2 | 6 | 33.3% | 0 | 0 | 0.0% | -2.0 |
| 2026-02-26 | DAL vs. SAC | L | 11.9 | 1 | 2 | 4 | 0 | 0 | 0 | 0 | 2 | 0.0% | 0 | 2 | 0.0% | 1 | 2 | 50.0% | -1.0 |
| 2026-02-24 | DAL @ BKN | W | 10.8 | 0 | 4 | 0 | 1 | 0 | 3 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-02-22 | DAL @ IND | W | 11.6 | 2 | 0 | 3 | 0 | 0 | 0 | 1 | 4 | 25.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -6.0 |
| 2026-02-20 | DAL @ MIN | L | 26.1 | 13 | 1 | 6 | 0 | 0 | 0 | 6 | 10 | 60.0% | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 11.0 |
| 2026-02-12 | DAL @ LAL | L | 18.9 | 3 | 0 | 3 | 1 | 0 | 1 | 1 | 3 | 33.3% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | -22.0 |
| 2026-02-10 | DAL @ PHX | L | 15.4 | 2 | 2 | 3 | 1 | 0 | 1 | 1 | 4 | 25.0% | 0 | 3 | 0.0% | 0 | 0 | 0.0% | -11.0 |
| 2026-02-07 | DAL @ SAS | L | 16.6 | 4 | 0 | 7 | 0 | 0 | 0 | 2 | 4 | 50.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 18.0 |
| 2026-02-03 | ORL @ OKC | L | 5.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -10.0 |
| 2026-02-01 | ORL @ SAS | L | 9.5 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-01-30 | ORL vs. TOR | W | 10.3 | 3 | 0 | 1 | 0 | 0 | 2 | 1 | 2 | 50.0% | 1 | 1 | 100.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-01-28 | ORL @ MIA | W | 19.4 | 5 | 1 | 9 | 0 | 0 | 1 | 2 | 3 | 66.7% | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 9.0 |
| 2026-01-26 | ORL @ CLE | L | 18.3 | 3 | 3 | 3 | 2 | 0 | 0 | 1 | 3 | 33.3% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 1.0 |
| 2026-01-22 | ORL vs. CHA | L | 16.0 | 3 | 2 | 1 | 0 | 0 | 0 | 1 | 7 | 14.3% | 1 | 5 | 20.0% | 0 | 0 | 0.0% | -4.0 |
| 2026-01-18 | ORL @ MEM | L | 3.1 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -6.0 |
| 2026-01-15 | ORL @ MEM | W | 12.5 | 2 | 0 | 2 | 0 | 0 | 0 | 1 | 5 | 20.0% | 0 | 3 | 0.0% | 0 | 0 | 0.0% | -10.0 |
| 2026-01-11 | ORL vs. NOP | W | 11.9 | 2 | 0 | 1 | 0 | 0 | 0 | 1 | 4 | 25.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -7.0 |
| 2026-01-09 | ORL vs. PHI | L | 17.0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 3 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 2.0 |
| 2026-01-07 | ORL @ BKN | W | 17.3 | 3 | 1 | 5 | 2 | 0 | 0 | 1 | 3 | 33.3% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 4.0 |
| 2026-01-06 | ORL @ WAS | L | 27.5 | 3 | 3 | 5 | 1 | 0 | 0 | 1 | 7 | 14.3% | 1 | 6 | 16.7% | 0 | 0 | 0.0% | 11.0 |
| 2026-01-04 | ORL vs. IND | W | 13.9 | 3 | 0 | 2 | 0 | 1 | 0 | 1 | 2 | 50.0% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 11.0 |
| 2026-01-02 | ORL @ CHI | L | 17.8 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 1.0 |
| 2025-12-31 | ORL @ IND | W | 23.6 | 4 | 1 | 1 | 1 | 0 | 0 | 2 | 7 | 28.6% | 0 | 3 | 0.0% | 0 | 0 | 0.0% | 3.0 |
| 2025-12-29 | ORL @ TOR | L | 28.1 | 10 | 4 | 2 | 1 | 0 | 1 | 4 | 8 | 50.0% | 2 | 6 | 33.3% | 0 | 0 | 0.0% | -13.0 |
| 2025-12-27 | ORL vs. DEN | W | 22.7 | 0 | 1 | 6 | 0 | 0 | 0 | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -12.0 |
| 2025-12-26 | ORL vs. CHA | L | 19.6 | 8 | 4 | 3 | 0 | 0 | 0 | 3 | 5 | 60.0% | 2 | 4 | 50.0% | 0 | 0 | 0.0% | -11.0 |
| 2025-12-23 | ORL @ POR | W | 34.9 | 16 | 4 | 7 | 1 | 0 | 0 | 6 | 9 | 66.7% | 4 | 6 | 66.7% | 0 | 0 | 0.0% | 7.0 |
| 2025-12-22 | ORL @ GSW | L | 25.9 | 7 | 3 | 4 | 4 | 0 | 1 | 2 | 6 | 33.3% | 1 | 3 | 33.3% | 2 | 2 | 100.0% | 0.0 |
| 2025-12-20 | ORL @ UTA | W | 18.2 | 5 | 1 | 2 | 1 | 0 | 0 | 2 | 7 | 28.6% | 1 | 6 | 16.7% | 0 | 0 | 0.0% | 5.0 |
| 2025-12-18 | ORL @ DEN | L | 19.1 | 5 | 0 | 4 | 0 | 0 | 0 | 1 | 2 | 50.0% | 1 | 2 | 50.0% | 2 | 2 | 100.0% | -20.0 |
| 2025-12-13 | ORL @ NYK | L | 9.5 | 3 | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 50.0% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | -10.0 |
| 2025-12-09 | ORL vs. MIA | W | 17.0 | 0 | 2 | 4 | 0 | 0 | 1 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 5.0 |
| 2025-12-07 | ORL @ NYK | L | 20.5 | 6 | 1 | 2 | 1 | 0 | 1 | 2 | 5 | 40.0% | 2 | 4 | 50.0% | 0 | 0 | 0.0% | -9.0 |
| 2025-12-05 | ORL vs. MIA | W | 16.0 | 7 | 0 | 2 | 0 | 0 | 0 | 3 | 5 | 60.0% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | -4.0 |
| 2025-12-03 | ORL vs. SAS | L | 6.8 | 5 | 0 | 0 | 1 | 0 | 0 | 2 | 3 | 66.7% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | -1.0 |
| 2025-12-01 | ORL vs. CHI | W | 18.7 | 0 | 0 | 6 | 1 | 0 | 1 | 0 | 2 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 13.0 |
| 2025-11-28 | ORL @ DET | W | 18.4 | 0 | 1 | 3 | 1 | 0 | 0 | 0 | 2 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 13.0 |
| 2025-11-25 | ORL @ PHI | W | 15.9 | 10 | 1 | 3 | 1 | 0 | 0 | 3 | 4 | 75.0% | 2 | 3 | 66.7% | 2 | 2 | 100.0% | 7.0 |
| 2025-11-23 | ORL @ BOS | L | 24.7 | 3 | 1 | 6 | 0 | 0 | 0 | 1 | 6 | 16.7% | 1 | 4 | 25.0% | 0 | 0 | 0.0% | 8.0 |
| 2025-11-22 | ORL vs. NYK | W | 16.2 | 0 | 1 | 3 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 3.0 |
| 2025-11-20 | ORL vs. LAC | W | 5.1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -3.0 |
| 2025-11-18 | ORL vs. GSW | W | 14.9 | 8 | 0 | 3 | 1 | 0 | 1 | 3 | 3 | 100.0% | 2 | 2 | 100.0% | 0 | 0 | 0.0% | 1.0 |
| 2025-11-16 | ORL @ HOU | L | 15.3 | 0 | 2 | 2 | 1 | 0 | 0 | 0 | 4 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -8.0 |
| 2025-11-14 | ORL vs. BKN | W | 13.1 | 0 | 1 | 2 | 3 | 0 | 0 | 0 | 2 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -5.0 |
| 2025-11-12 | ORL @ NYK | W | 13.0 | 0 | 1 | 3 | 2 | 0 | 0 | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -3.0 |
| 2025-11-10 | ORL vs. POR | W | 5.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 4.0 |
| 2025-11-09 | ORL vs. BOS | L | 10.2 | 0 | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -14.0 |
| 2025-11-07 | ORL vs. BOS | W | 7.9 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | -11.0 |
| 2025-11-04 | ORL @ ATL | L | 7.5 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 2 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -7.0 |
| 2025-11-01 | ORL @ WAS | W | 14.7 | 6 | 2 | 1 | 0 | 0 | 0 | 3 | 4 | 75.0% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 4.0 |
| 2025-10-30 | ORL @ CHA | W | 13.9 | 5 | 0 | 0 | 1 | 0 | 0 | 2 | 4 | 50.0% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 10.0 |
| 2025-10-29 | ORL @ DET | L | 8.9 | 3 | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 50.0% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | -7.0 |
| 2025-10-27 | ORL @ PHI | L | 10.3 | 2 | 3 | 2 | 1 | 0 | 0 | 1 | 1 | 100.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 5.0 |
| 2025-10-25 | ORL vs. CHI | L | 14.4 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 5 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -10.0 |
| 2025-10-24 | ORL vs. ATL | L | 19.6 | 4 | 1 | 2 | 0 | 1 | 1 | 2 | 4 | 50.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -9.0 |
| 2025-10-22 | ORL vs. MIA | W | 23.5 | 0 | 2 | 3 | 0 | 1 | 2 | 0 | 4 | 0.0% | 0 | 3 | 0.0% | 0 | 0 | 0.0% | -17.0 |